Common treatments, such as Ritalin and similar drugs, often manage symptoms but do not address the root cause. The author proposes ADHD as a metabolic condition stemming from the brain’s attempt to maintain elevated blood glucose levels, linking this to potential new treatment options using diabetes medications.

The theory suggests that during fetal development, if the mother experiences high blood glucose levels, the fetus adapts to this environment, leading to a lifelong tendency to maintain slightly elevated glucose levels. This adaptation involves the brain activating potassium channels prematurely, altering glucose regulation. This miscalibration leads to desensitization of the sympathetic nervous system, particularly the adrenaline system, resulting in periods of low energy and reduced control over motor activity, which manifests as hyperactivity.

A critical aspect of the theory is the connection between glucose dysregulation and the symptoms of ADHD. When energy levels in muscle tissues are insufficient due to impaired glucose regulation, it can cause spontaneous, uncontrolled movements that are perceived as hyperactivity. This explanation ties the biological underpinnings of ADHD to observable behaviors.

The author highlights an existing family of diabetes drugs, sulfonylureas, as a potential treatment for ADHD. These drugs work by inhibiting potassium channels, addressing the metabolic miscalibration proposed in the theory. Sulfonylureas have been used safely for decades and are inexpensive, making them an accessible option for patients. Administering these drugs could alleviate ADHD symptoms as long as the treatment continues.

The theory also underscores the importance of systematic clinical trials to test the efficacy of sulfonylureas for ADHD. The author recounts discussions with leading ADHD specialists who acknowledged the validity of the theory but faced conflicts of interest that hindered further exploration. This highlights the need for independent researchers and clinicians to pursue this line of inquiry.

In conclusion, the author provides a novel perspective on ADHD, framing it as a metabolic condition linked to glucose regulation. This approach not only challenges traditional views of ADHD but also offers a promising avenue for treatment using existing, well-tested medications. The theory emphasizes the need for further research and collaboration to validate these findings and improve the quality of life for individuals with ADHD.